Form 4: CVS Health Corp: President and CEO J. David Joyner Reports Stock Transaction
SEC Form 4 Filing
J. David Joyner, President and CEO of CVS Health Corp, reported the surrender of 1,944 common stock shares to cover withholding taxes upon the vesting of a restricted stock award on February 28, 2025.
Summary
- On February 28, 2025, J. David Joyner, the President and CEO of CVS Health Corp, reported a transaction involving the company's common stock.
- The transaction involved the surrender of 1,944 shares of common stock.
- These shares were surrendered to cover withholding taxes due upon the vesting of a restricted stock award.
- The price per share for the transaction was $65.72.
- Following the transaction, Joyner directly owns 46,717 shares of CVS Health Corp common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of stock transaction: surrender of shares for tax withholding. |
| 03/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.